focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
I believe LD explains the reasoning behind the program design about 17 minutes in on the recent AGM recording.
https://wetransfer.com/downloads/7ad17c6f210a029507e49981a7b7c63720221208122613/688b32
https://www.share-talk.com/traders-cafe-with-zak-mir-bulletin-board-heroes-sunday-27th-november-2022-via-vox-markets/
Zak, certainly likes Scancell, 36p target!
Omicron boosters probably aren’t very effective against mild Covid illness, but will likely prevent hospitalizations, experts say.
KEY POINTS
The CDC, in a real-world study, found the omicron Covid boosters are less than 50% effective against mild illness across almost all adult age groups when compared to people who are unvaccinated.
But people who received the boosters were better off than those who only got the old shots, with their protection increasing 28% to 56%.
The study did not look at hospitalization, but experts believe the shots will provide strong protection against severe outcomes.
https://www.thetimes.co.uk/article/tailor-made-treatments-improve-cancer-care-nhs-latest-s0t970nl3
Interesting article relating to The Royal Marsden which I believe is one of the Modi-1 in Breast, Head and Neck, Ovarian or Renal Cancer trial centres.
WHO is tracking omicron BA.4 and BA.5 subvariants as they spread through Africa and Europe.
https://www.cnbc.com/2022/04/15/who-tracks-omicron-bapoint4-and-bapoint5-subvariants-as-they-spread-through-africa-and-europe.html